PHASE-I TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, EPIRUBICIN AND 5-FLUOROURACIL (CEF) FOR STAGE-II BREAST-CANCER

被引：0
|
作者：
JONES, SE
MENNEL, RG
PETERS, GN
WESTRICK, MA
BROOKS, BD
KNOX, SM
MCGUFFEY, P
机构：
来源：
INVESTIGATIONAL NEW DRUGS | 1988年 / 6卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：195 / 198
页数：4
相关论文
共 50 条
  • [21] Systemic immune effects of adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide and/or radiotherapy in breast cancer: a longitudinal study
    Fariba Mozaffari
    Christina Lindemalm
    Aniruddha Choudhury
    Helena Granstam-Björneklett
    Mats Lekander
    Bo Nilsson
    Marja-Leena Ojutkangas
    Anders Österborg
    Leif Bergkvist
    Håkan Mellstedt
    Cancer Immunology, Immunotherapy, 2009, 58 : 111 - 120
  • [22] PHASE-I TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND 5-FLUOROURACIL PLUS INTERFERON-ALPHA-2B IN PATIENTS WITH ADVANCED BREAST-CANCER
    SPARANO, JA
    WADLER, S
    LIEBES, L
    ROBERT, NJ
    SCHWARTZ, EL
    DUTCHER, JP
    CANCER RESEARCH, 1993, 53 (15) : 3509 - 3512
  • [23] Adjuvant Therapy of Breast Cancer with Pirarubicin Versus Epirubicin in Combination with Cyclophosphamide and 5-fluorouracil
    Li, Jun-Jie
    Di, Gen-Hong
    Tang, Li-Chen
    Yu, Ke-Da
    Hu, Zhen
    Liu, Guang-Yu
    Lu, Jing-Song
    Wu, Jiong
    Han, Qi-Xia
    Shen, Zhen-Zhou
    Shao, Zhi-Ming
    BREAST JOURNAL, 2011, 17 (06): : 657 - 660
  • [24] Nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in neoadjuvant chemotherapy for resectable breast cancer: Phase II trial
    Kin, T.
    Fujihara, M.
    Yoshimura, Y.
    Kajiwara, Y.
    Ito, M.
    Ohtani, S.
    Taniguchi, K.
    Morito, T.
    Takada, S.
    Ichimura, K.
    BREAST, 2017, 32 : S79 - S80
  • [25] Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer
    E. Esteban
    A.J. Lacave
    J.L. Fernández
    N. Corral
    J.M. Buesa
    E. Estrada
    I. Palacio
    J.M. Vieitez
    I. Muñiz
    E. Alvarez
    Breast Cancer Research and Treatment, 1999, 58 : 141 - 150
  • [26] Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer
    Esteban, E
    Lacave, AJ
    Fernández, JL
    Corral, N
    Buesa, JM
    Estrada, E
    Palacio, I
    Vieitez, JM
    Muñiz, I
    Alvarez, E
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 58 (02) : 141 - 150
  • [27] A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancer
    Erman, M
    Baltali, E
    Karaoglu, A
    Abali, H
    Engin, H
    Ozisik, Y
    Guler, N
    Altundag, K
    Tekuzman, G
    CANCER INVESTIGATION, 2005, 23 (03) : 215 - 221
  • [28] Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer
    Baldini, E
    Gardin, G
    Giannessi, PG
    Evangelista, G
    Roncella, M
    Prochilo, T
    Collecchi, P
    Rosso, R
    Lionetto, R
    Bruzzi, P
    Mosca, F
    Conte, PF
    ANNALS OF ONCOLOGY, 2003, 14 (02) : 227 - 232
  • [29] Doxorubicin and Cyclophosphamide versus Cyclophosphamide, Methotrexate, and 5-Fluorouracil as Adjuvant Chemotherapy in Breast Cancer
    Livi, L.
    Saieva, C.
    Borghesi, S.
    Cardillo, C. De Luca
    Scotti, V.
    Mangoni, M.
    Greto, D.
    Cataliotti, L.
    Paiar, F.
    Bianchi, S.
    Biti, G. P.
    JOURNAL OF CHEMOTHERAPY, 2009, 21 (05) : 558 - 565
  • [30] POSTOPERATIVE ADJUVANT CHEMOTHERAPY OF STAGE-II BREAST-CANCER IN POSTMENOPAUSAL WOMEN
    NORTON, L
    CANCER INVESTIGATION, 1986, 4 (05) : 498 - 499
12345